Skip to main content
Equibles

Serge Valenz

Analyst

Needham

Equibles does not estimate personal net worth.

About Serge Valenz

Serge Valenz is recorded as Analyst at Needham. Serge Valenz has spoken on 1 earnings call across 1 company, most recently for Collegium Pharmaceutical, Inc on November 5, 2026. The companies whose calls Serge Valenz spoke on are classified in the Healthcare sector.

Serge Valenz on recent calls

“First on the ADHD portfolio, given the differentiation between your two products and the fact that they address slightly different patient segments, should we expect the seasonality impacts to differ on each of the products?”
Analyst — Needham, Q3 2026 Collegium Pharmaceutical, Inc. Earnings Conference Call ·

Affiliation history

  • Needham

    Analyst

    Transcript header (unverified)

    Current

Company network

Recent activity